DK0946150T3 - Oral sammensætning indeholdende mindst et farmaceutisk aktivt stof i en i vandigt medium kvældningsdygtig matrix - Google Patents

Oral sammensætning indeholdende mindst et farmaceutisk aktivt stof i en i vandigt medium kvældningsdygtig matrix

Info

Publication number
DK0946150T3
DK0946150T3 DK97944810T DK97944810T DK0946150T3 DK 0946150 T3 DK0946150 T3 DK 0946150T3 DK 97944810 T DK97944810 T DK 97944810T DK 97944810 T DK97944810 T DK 97944810T DK 0946150 T3 DK0946150 T3 DK 0946150T3
Authority
DK
Denmark
Prior art keywords
aqueous medium
composition containing
active substance
pharmaceutically active
oral composition
Prior art date
Application number
DK97944810T
Other languages
Danish (da)
English (en)
Inventor
Karsten Cremer
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Application granted granted Critical
Publication of DK0946150T3 publication Critical patent/DK0946150T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK97944810T 1996-09-28 1997-08-29 Oral sammensætning indeholdende mindst et farmaceutisk aktivt stof i en i vandigt medium kvældningsdygtig matrix DK0946150T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19640062A DE19640062B4 (de) 1996-09-28 1996-09-28 Orale Zubereitung, enthaltend in einer in wässrigem Medium quellbaren Matrix wenigstens einen pharmazeutischen Wirkstoff
PCT/EP1997/004717 WO1998013028A1 (de) 1996-09-28 1997-08-29 Orale zubereitung, enthaltend in einer in wässrigem medium quellbaren matrix wenigstens einen pharmazeutischen wirkstoff

Publications (1)

Publication Number Publication Date
DK0946150T3 true DK0946150T3 (da) 2002-06-24

Family

ID=7807265

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97944810T DK0946150T3 (da) 1996-09-28 1997-08-29 Oral sammensætning indeholdende mindst et farmaceutisk aktivt stof i en i vandigt medium kvældningsdygtig matrix

Country Status (23)

Country Link
US (1) US6238698B1 (cs)
EP (1) EP0946150B1 (cs)
JP (1) JP2001504807A (cs)
KR (1) KR100493139B1 (cs)
CN (1) CN1139378C (cs)
AT (1) ATE213933T1 (cs)
AU (1) AU724802B2 (cs)
CA (1) CA2260845C (cs)
CZ (1) CZ291258B6 (cs)
DE (2) DE19640062B4 (cs)
DK (1) DK0946150T3 (cs)
ES (1) ES2174296T3 (cs)
HU (1) HU227865B1 (cs)
IL (1) IL129171A (cs)
MY (1) MY130959A (cs)
NO (1) NO991477L (cs)
NZ (1) NZ333401A (cs)
PL (1) PL188392B1 (cs)
PT (1) PT946150E (cs)
SI (1) SI0946150T1 (cs)
SK (1) SK282709B6 (cs)
WO (1) WO1998013028A1 (cs)
ZA (1) ZA978625B (cs)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR030557A1 (es) * 2000-04-14 2003-08-27 Jagotec Ag Una tableta en multicapa de liberacion controlada y metodo de tratamiento
US8487002B2 (en) * 2002-10-25 2013-07-16 Paladin Labs Inc. Controlled-release compositions
TWI319713B (en) * 2002-10-25 2010-01-21 Sustained-release tramadol formulations with 24-hour efficacy
US20060172006A1 (en) * 2003-10-10 2006-08-03 Vincent Lenaerts Sustained-release tramadol formulations with 24-hour clinical efficacy
CA2491665A1 (fr) * 2004-12-24 2006-06-24 Louis Cartilier Formulation de comprime pour liberation soutenue de principe actif
BRPI0615860B8 (pt) 2005-09-09 2021-05-25 Labopharm Barbados Ltd composição farmacêutica de liberação prolongada monolítica sólida
US20080286343A1 (en) * 2007-05-16 2008-11-20 Dzenana Cengic Solid form
US8226967B2 (en) 2008-11-27 2012-07-24 Basf Se Surface active proteins as excipients in solid pharmaceutical formulations

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1237904B (it) 1989-12-14 1993-06-18 Ubaldo Conte Compresse a rilascio a velocita' controllata delle sostanze attive
CA2041774C (en) * 1990-11-27 1994-04-19 Mircea A. Mateescu Use of cross-linked amylose as a matrix for the slow release of biologically active compounds
US5603956A (en) * 1990-11-27 1997-02-18 Labopharm Inc. Cross-linked enzymatically controlled drug release
WO1994002121A1 (en) * 1992-07-24 1994-02-03 Labopharm Inc. Cross-linked polyhydroxylic material for enzymatically controlled drug release
US5616343A (en) * 1993-03-25 1997-04-01 Labopharm, Inc. Cross-linked amylose as a binder/disintegrant in tablets
DE4341442C2 (de) 1993-12-04 1998-11-05 Lohmann Therapie Syst Lts Vorrichtung zur kontrollierten Freisetzung von Wirkstoffen sowie ihre Verwendung
DE4416926C2 (de) 1994-05-13 2000-01-13 Lohmann Therapie Syst Lts Verfahren zur Herstellung von Vorrichtungen zur kontrollierten Freisetzung von Wirkstoffen
IT1282650B1 (it) * 1996-02-19 1998-03-31 Jagotec Ag Compressa farmaceutica,caratterizzata da elevato aumento di volume a contatto con liquidi biologici
WO2007095324A1 (en) 2006-02-14 2007-08-23 The Procter & Gamble Company Personal care compositions comprising responsive particles

Also Published As

Publication number Publication date
JP2001504807A (ja) 2001-04-10
WO1998013028A1 (de) 1998-04-02
SI0946150T1 (en) 2002-08-31
HUP9903115A2 (hu) 2000-02-28
EP0946150B1 (de) 2002-03-06
HUP9903115A3 (en) 2000-03-28
DE19640062B4 (de) 2006-04-27
NO991477D0 (no) 1999-03-26
SK38799A3 (en) 2000-03-13
IL129171A (en) 2001-11-25
CA2260845A1 (en) 1998-04-02
PL332577A1 (en) 1999-09-27
AU724802B2 (en) 2000-09-28
US6238698B1 (en) 2001-05-29
HU227865B1 (en) 2012-05-29
CN1231600A (zh) 1999-10-13
SK282709B6 (sk) 2002-11-06
ATE213933T1 (de) 2002-03-15
NO991477L (no) 1999-03-26
PT946150E (pt) 2002-08-30
CA2260845C (en) 2005-11-22
CZ101399A3 (cs) 1999-07-14
CN1139378C (zh) 2004-02-25
PL188392B1 (pl) 2005-01-31
CZ291258B6 (cs) 2003-01-15
NZ333401A (en) 1999-10-28
IL129171A0 (en) 2000-02-17
DE19640062A1 (de) 1998-04-09
EP0946150A1 (de) 1999-10-06
AU4619397A (en) 1998-04-17
KR100493139B1 (ko) 2005-06-02
ZA978625B (en) 1998-03-26
ES2174296T3 (es) 2002-11-01
DE59706576D1 (de) 2002-04-11
KR20010029533A (ko) 2001-04-06
MY130959A (en) 2007-07-31

Similar Documents

Publication Publication Date Title
ES2158067T3 (es) Dispositivo de administracion transdermico.
BR9708772A (pt) "comprimidos famacêuticos de liberação controlada que contém um veìculo à base de amilose reticulada e hidróxi propil metil celulose"
YU12591A (sh) Postupak za izradu transdermalnog terapijskog sistema sa aktivnom materijom tulobuterolom
PT739199E (pt) Adesivo de estradiol com agente reforcador da penetracao
ATE269709T1 (de) Tablette mit verzögerter freigabe enthaltend einen blutzuckersenkenden wirkstoff und einen antihyperglyzemischen wirkstoff
ATE164769T1 (de) Pflaster mit hohem gehalt an weichmachenden inhaltsstoffen
ES2157297T3 (es) Granulos entericos de duloxetina.
WO2002034200A3 (de) Transdermale therapeutische systeme mit lichtempfindlichen wirkstoffen
MY111126A (en) Transdermal therapeutic system comprising the active substance acetylsalicylic acid.
DK0946150T3 (da) Oral sammensætning indeholdende mindst et farmaceutisk aktivt stof i en i vandigt medium kvældningsdygtig matrix
NO970610L (no) Sammensetning for selektiv frigjöring av en aktiv ingrediens
AR043070A1 (es) Sistema monolitico que contiene una o mas drogas, formado por tres capas con diferentes mecanismos de liberacion
FI900315A0 (fi) Saett att framstaella ett ytligt terapeutiskt system vilket innehaoller tillvaext av elakartade celler och tillvaextfoerhindrande aktivaemne, speciellt 5-fluoruracil.
ES2176702T3 (es) Antimicoticos con alta liberacion de sustancia activa.
AR016350A1 (es) Uso de un sensibilizador a insulina, un secretagogo de insulina y un agente antihiperglucemico inhibidor de alfa-glucosidasa para prepararmedicamentos
FI971833A (fi) Lapsiturvallinen pakkaus vaikuttavaa ainetta sisältävää laastaria varten
ES545067A0 (es) Perfeccionamientos en formas farmaceuticas solidas para uso oral
ES2139932T3 (es) Sistema terapeutico percutaneo a base de estradiol con aditivos higroscopicos.
WO1996008237A3 (de) Selbstklebendes pflaster zur abgabe von wirkstoff an die umgebung eines trägers
SE9501670D0 (sv) Omläggningsset
LV10749A (lv) Transdermala terapeitiska sistema fizostigmina uzliksanai uz adas un tas izgatavosanas panemiens
HUP9902681A2 (hu) Térhálósított amilózt és hidroxi-propil-metil-cellulózt tartalmazó hordozóval készült szabályozott felszabadulású tabletta gyógyszerkészítmény
IT1275267B (it) Forme farmaceutiche a rilascio modificato di canrenoato di potassio costituite da matrici idrofile rivestite
NO991047D0 (no) Transdermal terapeutisk tilnµrming involverende en kombinasjon av aktive substanser inneholdende °striol
CA2198092A1 (en) Transdermal therapeutic system with protection against hydrolysis